Ann Childress MD

Psychiatry•Las Vegas, NV

Child & Adolescent Psychiatry

Physician

Join to View Full Profile

4000 E Charleston BlvdSte 130Las Vegas, NV 89104
Phone+1 702-968-4000
Fax+1 702-838-6749

Education & Training

Medical University of South CarolinaFellowship, Child and Adolescent Psychiatry, 1991 - 1993
Medical University of South CarolinaResidency, Psychiatry, 1987 - 1991
Medical University of South CarolinaClass of 1987

Certifications & Licensure

NV State Medical License 1997 - 2025
SC State Medical License 1988 - 1997
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Clinical Trials

Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD Start of enrollment: 2005 Jun 01
Completed
Phase 3
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD Start of enrollment: 2004 Sep 01
Completed
Phase 2
PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01
Completed
Phase 3
Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30
Completed
Phase 3
TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) Start of enrollment: 2014 Mar 01
Completed
Phase 3
PRC-063 in Adolescent ADHD Start of enrollment: 2014 Apr 01
Completed
Phase 3
Open-label Safety Study in Adults With ADHD Start of enrollment: 2014 Jun 01
Completed
Phase 3
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD Start of enrollment: 2014 May 01
Completed
Phase 3
PRC-063 in an ADULT Workplace Environment Start of enrollment: 2014 Aug 01
Completed
Phase 3
Dasotraline Pediatric ADHD Study Start of enrollment: 2015 Apr 01
Completed
Phase 2, Phase 3
Dasotraline Pediatric Extension Study Start of enrollment: 2015 Jun 30
Completed
Phase 3
Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder Start of enrollment: 2015 Aug 21
Completed
Phase 3
Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) Start of enrollment: 2015 Jun 18
Completed
Phase 3
A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom Setting Start of enrollment: 2015 Jul 01
Completed
Phase 3
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD Start of enrollment: 2016 Sep 01
Unknown status
Phase 4
Reference Database Development for the Quotient® System iPad Test Start of enrollment: 2016 Apr 01
Completed
Not Applicable
Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension Start of enrollment: 2019 Oct 04
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Viloxazine Extended-Release Administered With Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Phase 4, Open-Label Trial.
Ann Childress, Kobby Asubonteng, Georgette Cox, Jami Earnest, Kimberley Hayman
Journal of Child and Adolescent Psychopharmacology. 2025-02-27
1 citations
Safety and Efficacy of Brexpiprazole in the Treatment of Irritability Associated with Autism Spectrum Disorder: An 8-Week, Phase 3, Randomized, Double-Blind, Placebo-C...
Caroline Ward, Ann Childress, Krista Martinko, Dalei Chen, Klaus Groes Larsen
Journal of Child and Adolescent Psychopharmacology. 2025-02-19
1 citations
Quality of Life and Outcomes Associated with Adverse Effects in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder and Their Parents/Caregivers.
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Louise Yu
Journal of Child and Adolescent Psychopharmacology. 2025-02-01

Press Mentions

CDC: Half of People with ADHD Diagnosed in AdulthoodOctober 15th, 2024
Corium's Novel ADHD Medication AZSTARYS® (Serdexmethylphenidate and Dexmethylphenidate) Had No Clinically Significant Impact on Children's Weight and Height Growth RateMay 22nd, 2023
A Once-Daily Stimulator for ADHD Is Safe, Effective for 1 YearMarch 10th, 2023
Join now to see all

Ann Childress MD

Dr. Childress is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.